Qiyu Fang

发表

Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor

J Zhang, Caicun Zhou, Jie Luo, 2022, Clinical Medicine Insights: Oncology.

Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapse

F. Hirsch, R. Dziadziuszko, Jie Chen, 2021, Translational lung cancer research.

Predictive value of unmethylated RASSF1A on disease progression in non-small cell lung cancer patients receiving pemetrexed-based chemotherapy.

Caicun Zhou, Songwen Zhou, B. Su, 2019, Cancer Biomarkers.

Single-Cell Sequencing, an Advanced Technology in Lung Cancer Research

Haoyue Guo, Yayi He, Sha Zhao, 2021, OncoTargets and therapy.

OTT_A_295102 1895..1909

Haoyue Guo, Yayi He, Sha Zhao, 2021 .

Risk-score model to predict prognosis of malignant airway obstruction after interventional bronchoscopy

Liping Zhang, L. Hou, Yayi He, 2021, Translational lung cancer research.

FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III

Caicun Zhou, Liping Zhang, Chunyan Wu, 2021, Journal for ImmunoTherapy of Cancer.

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients

C. Ding, Leilei Wu, Shengnan Jin, 2018, Heliyon.

Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis

Songwen Zhou, Qin‐Fang Deng, Aditi P. Singh, 2020, Cancer medicine.

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma

Junjie Zhu, Caicun Zhou, Chunyan Wu, 2021, OncoTargets and therapy.

Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy

J Zhang, Caicun Zhou, Yayi He, 2022, Clinical and experimental pharmacology & physiology.

Exosomal long non-coding RNA MSTRG.292666.16 is associated with osimertinib (AZD9291) resistance in non-small cell lung cancer

Songwen Zhou, Yu-chen Bao, Qin‐Fang Deng, 2020, Aging.

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

Yayi He, Peixin Chen, Hao Wang, 2021, Annals of translational medicine.

Knockdown of Long Noncoding RNA ENST457720 Inhibits Proliferation of Non-Small Cell Lung Cancer Cells In Vitro and In Vivo

S. Meng, J. Yu, Qiyu Fang, 2018, Oncology research.

Microbes in lung cancer initiation, treatment, and outcome: boon or bane?

Junjie Zhu, Haoyue Guo, Yayi He, 2021, Seminars in cancer biology.

Programmable DNA Circuit-Facilitated Determination of Circulating Extracellular Vesicle PD-L1 for Lung Cancer Diagnosis and Immunotherapy Response Prediction.

Caicun Zhou, Jiayu Li, Wei Li, 2023, ACS applied materials & interfaces.

Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis

Songwen Zhou, Qin‐Fang Deng, Xian-xiu Ji, 2020, Journal of Cancer.

Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer

Caicun Zhou, Songwen Zhou, Qin‐Fang Deng, 2023, Frontiers in oncology.

Risk-score model to predict prognosis of malignant airway obstruction after interventional bronchoscopy

Yayi He, Peixin Chen, Hao Wang, 2021, Translational lung cancer research.